These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37734900)

  • 1. Patients' experience of using colonoscopy as a diagnostic test after a positive FOBT/FIT: a systematic review of the quantitative literature.
    Kayal G; Kerrison R; Hirst Y; von Wagner C
    BMJ Open; 2023 Sep; 13(9):e071391. PubMed ID: 37734900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
    Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
    Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
    Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
    Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition to quantitative faecal immunochemical testing from guaiac faecal occult blood testing in a fully rolled-out population-based national bowel screening programme.
    Clark G; Strachan JA; Carey FA; Godfrey T; Irvine A; McPherson A; Brand J; Anderson AS; Fraser CG; Steele RJ
    Gut; 2021 Jan; 70(1):106-113. PubMed ID: 32234803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of alternative technologies compared with faecal immunochemical test and/or colonoscopy in colorectal cancer screening: A systematic review.
    Ali O; Gupta S; Brain K; Lifford KJ; Paranjothy S; Dolwani S
    J Med Screen; 2023 Mar; 30(1):14-27. PubMed ID: 36039489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonoscopy quality assessment in a mass population screening programme based on faecal occult blood test.
    Binefa G; García M; Milà N; Rodríguez L; Rodríguez-Moranta F; Guardiola J; Moreno V
    Rev Esp Enferm Dig; 2013 Aug; 105(7):400-8. PubMed ID: 24206550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
    Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
    J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using CT colonography as a triage technique after a positive faecal occult blood test in colorectal cancer screening.
    Liedenbaum MH; van Rijn AF; de Vries AH; Dekker HM; Thomeer M; van Marrewijk CJ; Hol L; Dijkgraaf MG; Fockens P; Bossuyt PM; Dekker E; Stoker J
    Gut; 2009 Sep; 58(9):1242-9. PubMed ID: 19625276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort.
    Bjerrum A; Andersen O; Fischer A; Lindebjerg J; Lynge E
    Int J Cancer; 2017 Aug; 141(3):503-511. PubMed ID: 28463410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimising faecal occult blood screening:retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm.
    Geraghty J; Butler P; Seaman H; Snowball J; Sarkar S; Blanks R; Halloran S; Bodger K; Rees CJ
    Br J Cancer; 2014 Nov; 111(11):2156-62. PubMed ID: 25225905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Options for screening for colorectal cancer.
    Atkin W
    Scand J Gastroenterol Suppl; 2003; (237):13-6. PubMed ID: 12797674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient burden of colonoscopy after positive fecal immunochemical testing for colorectal cancer screening.
    Denters MJ; Deutekom M; Bossuyt PM; Fockens P; Dekker E
    Endoscopy; 2013; 45(5):342-9. PubMed ID: 23483433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of faecal occult blood tests requested outside the UK National Bowel Cancer Screening Programme.
    McDonald R; Tomlins A; Smith S; Harmston C
    J Clin Pathol; 2013 Apr; 66(4):330-4. PubMed ID: 23288919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study.
    Bertels L; Lucassen P; van Asselt K; Dekker E; van Weert H; Knottnerus B
    Scand J Prim Health Care; 2020 Dec; 38(4):487-498. PubMed ID: 33185121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
    Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.